Global Parkinsons Disease Drugs Market Size, Status and Forecast 2022

Table of Contents

Global Parkinsons Disease Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Parkinsons Disease Drugs
1.1 Parkinsons Disease Drugs Market Overview
1.1.1 Parkinsons Disease Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Parkinsons Disease Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Parkinsons Disease Drugs Market by Type
1.3.1 Madopar
1.3.2 Sinemet-CR
1.3.3 Trastal
1.3.4 COMT Inhibitor
1.3.5 Other
1.4 Parkinsons Disease Drugs Market by End Users/Application
1.4.1 Under 40 Years Old
1.4.2 40-65 Years Old
1.4.3 Above 65 Years Old

2 Global Parkinsons Disease Drugs Competition Analysis by Players
2.1 Parkinsons Disease Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 GSK
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Teva Pharmaceutical
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Abbvie
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Merck
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Akorn
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Kyowa Hakko Kirin Pharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Astellas Pharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Desitin Arzneimittel
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Endo Pharmaceuticals
3.12 F.Hoffmann-La Roche
3.13 H.Lundbeck
3.14 Valeant
3.15 Apokyn
3.16 Orion
3.17 Stada Arzneimittel
3.18 US WorldMeds
3.19 Valeant Pharmaceuticals

4 Global Parkinsons Disease Drugs Market Size by Type and Application (2012-2017)
4.1 Global Parkinsons Disease Drugs Market Size by Type (2012-2017)
4.2 Global Parkinsons Disease Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Parkinsons Disease Drugs in Future
4.4 Top Consumer/End Users of Parkinsons Disease Drugs

5 United States Parkinsons Disease Drugs Development Status and Outlook
5.1 United States Parkinsons Disease Drugs Market Size (2012-2017)
5.2 United States Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Parkinsons Disease Drugs Development Status and Outlook
6.1 EU Parkinsons Disease Drugs Market Size (2012-2017)
6.2 EU Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Parkinsons Disease Drugs Development Status and Outlook
7.1 Japan Parkinsons Disease Drugs Market Size (2012-2017)
7.2 Japan Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Parkinsons Disease Drugs Development Status and Outlook
8.1 China Parkinsons Disease Drugs Market Size (2012-2017)
8.2 China Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Parkinsons Disease Drugs Development Status and Outlook
9.1 India Parkinsons Disease Drugs Market Size (2012-2017)
9.2 India Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Parkinsons Disease Drugs Development Status and Outlook
10.1 Southeast Asia Parkinsons Disease Drugs Market Size (2012-2017)
10.2 Southeast Asia Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Parkinsons Disease Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Parkinsons Disease Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Parkinsons Disease Drugs Market Size by Application (2017-2022)

12 Parkinsons Disease Drugs Market Dynamics
12.1 Parkinsons Disease Drugs Market Opportunities
12.2 Parkinsons Disease Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Parkinsons Disease Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Parkinsons Disease Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source



List of Tables and Figures

Figure Parkinsons Disease Drugs Product Scope
Figure Global Parkinsons Disease Drugs Market Size (Million USD) (2012-2017)
Table Global Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinsons Disease Drugs Market Share by Regions in 2016
Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Parkinsons Disease Drugs Market Share by Type in 2016
Figure Madopar Market Size (Million USD) and Growth Rate (2012-2017)
Figure Sinemet-CR Market Size (Million USD) and Growth Rate (2012-2017)
Figure Trastal Market Size (Million USD) and Growth Rate (2012-2017)
Figure COMT Inhibitor Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Parkinsons Disease Drugs Market Share by Application in 2016
Table Key Downstream Customer in Under 40 Years Old
Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Under 40 Years Old (2012-2017)
Table Key Downstream Customer in 40-65 Years Old
Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in 40-65 Years Old (2012-2017)
Table Key Downstream Customer in Above 65 Years Old
Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Above 65 Years Old (2012-2017)
Table Parkinsons Disease Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Parkinsons Disease Drugs Market Size Share by Players in 2016
Figure Parkinsons Disease Drugs Market Size Share by Players in 2017
Table GSK Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Teva Pharmaceutical Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Teva Pharmaceutical (2012-2017)
Figure Teva Pharmaceutical Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Abbvie Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Abbvie (2012-2017)
Figure Abbvie Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Akorn Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Akorn (2012-2017)
Figure Akorn Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Astellas Pharma Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Astellas Pharma (2012-2017)
Figure Astellas Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Desitin Arzneimittel Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Desitin Arzneimittel (2012-2017)
Figure Desitin Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Endo Pharmaceuticals Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Endo Pharmaceuticals (2012-2017)
Figure Endo Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table F.Hoffmann-La Roche Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of F.Hoffmann-La Roche (2012-2017)
Figure F.Hoffmann-La Roche Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table H.Lundbeck Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of H.Lundbeck (2012-2017)
Figure H.Lundbeck Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Valeant Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant (2012-2017)
Figure Valeant Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Apokyn Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Apokyn (2012-2017)
Figure Apokyn Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Orion Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Orion (2012-2017)
Figure Orion Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Stada Arzneimittel Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Stada Arzneimittel (2012-2017)
Figure Stada Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table US WorldMeds Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of US WorldMeds (2012-2017)
Figure US WorldMeds Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Valeant Pharmaceuticals Basic Information List
Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2012-2017)
Figure Valeant Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016
Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2012
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2013
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2014
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2015
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2016
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017
Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2012
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2013
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2014
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2015
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2016
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Parkinsons Disease Drugs
Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2016
Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2017
Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2016
Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2017
Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2016
Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2017
Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Parkinsons Disease Drugs Market Size Share by Players in 2016
Figure China Parkinsons Disease Drugs Market Size Share by Players in 2017
Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Parkinsons Disease Drugs Market Size Share by Players in 2016
Figure India Parkinsons Disease Drugs Market Size Share by Players in 2017
Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2016
Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2017
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2017
Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2022
Figure United States Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017
Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2022
Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017
Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2022

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.